Table 4– Univariate regression analysis to identify predictors for diastolic dysfunction
Variablep-value#OR (95% CI)R
Age yrs<0.0011.136 (1.093–1.180)0.193
Female0.6630.910 (0.597–1.389)0.001
Sleep apnoea (AHI ≥15 events·h−1)0.0042.221 (1.290–3.827)0.033
AHI events·h−10.0011.041 (1.017–1.065)0.052
Desaturation index %0.0031.031 (1.011–1.052)0.003
Hypertension0.4871.257 (0.659–2.397)0.002
Diabetes0.1491.563 (0.853–2.865)0.008
Coronary artery disease0.0921.676 (0.919–3.058)0.011
Left ventricular mass g0.0211.004 (1.001–1.007)0.021
LVEDD0.4421.015 (0.977–1.054)0.002
BMI kg·m−20.0051.075 (1.022–1.130)0.032
Cardiac frequency beats·min−10.0101.024 (1.006–1.042)0.026
Systolic blood pressure mmHg0.1961.007 (0.996–1.018)0.006
Diastolic blood pressure mmHg0.3910.992 (0.974–1.010)0.003
AT1 antagonists0.0321.966 (1.060–3.647)0.018
Calcium channel blockers0.7180.925 (0.606–1.412)0.000
Diuretics0.0441.547 (1.012–2.365)0.016
Loop diuretics0.1811.809 (0.759–4.311)0.007
Thiazide0.0631.501 (0.979–2.300)0.013
Other diuretics0.2331.828 (0.678–4.925)0.006
Number of antihypertensives0.0801.161 (0.982–1.372)0.012
  • AHI: apnoea/hypopnoea index; LVEDD: left ventricular end-diastolic diameter; BMI: body mass index; AT1: angiotensin receptor 1. #: univariate analysis; : Nagelkerkes R2.